Acnecare

Quick links to important sections

Acnecare

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acnecare

Property Description
Active Ingredient Benzoyl Peroxide (BPO)
Form Topical preparations (creams, gels, washes, lotions)
Pharmacological Class Antiseptic agent and Keratolytic agent
Common Use Management of Acne Vulgaris
Origin Synthetic

What is Acnecare and What Class Does it Belong To?

Acnecare is a trade name for a medicinal product specifically classified as a topical anti-acne agent, defined by its active pharmaceutical ingredient, Benzoyl Peroxide (BPO). This compound is a synthetic chemical entity that holds a crucial dual role in pharmacology: it functions as both an antiseptic agent and a keratolytic agent. Benzoyl Peroxide is an organic peroxide compound. The dual pharmacological function is essential as it enables the treatment to interrupt multiple pathways contributing to the formation of acne lesions. Acnecare is typically marketed in over-the-counter (OTC) strengths, positioned for the broad patient group seeking accessible acne management.


What are the Forms and High-Level Composition of Acnecare?

Products containing Benzoyl Peroxide are formulated exclusively for topical administration, meaning they are designed to be applied directly onto the skin in the affected area, ensuring targeted delivery of the therapeutic agent. The BPO entity is available across diverse dosage forms, including creams, gels, lotions, foams, and washes. These preparations differ primarily based on the base/vehicle used, with BPO suspended in various non-greasy aqueous or emollient bases; the choice of vehicle defines the final consistency. Benzoyl Peroxide is an effective topical treatment for acne, and this standing supports its use in managing common inflammatory acne presentations.


What is the General Therapeutic Purpose of Acnecare?

The general therapeutic purpose of Acnecare is to manage and reduce the severity of acne by simultaneously addressing the key contributing factors of the condition, a principle clinically recognized by dermatological guidelines. As an antiseptic agent, its purpose is to effectively reduce the population of Cutibacterium acnes, the bacteria centrally implicated in acne pathogenesis, while its keratolytic action helps to clear follicular plugs by promoting the accelerated shedding of epidermal cells. The overall benefit is derived from this comprehensive approach: both controlling the source of bacterial infection and mitigating pore blockages, which leads to a decrease in existing inflammatory and non-inflammatory lesions.

Regulatory References

  1. NLM MedlinePlus: Benzoyl Peroxide

What side effects are possible with Acnecare?

Possible side effects and safety information

Adverse reactions to topical Benzoyl Peroxide (Acnecare's active ingredient) are classified by regulatory authorities, such as the FDA and EMA, and primarily affect the skin and subcutaneous tissue.

Adverse Reaction Scope Official Regulatory Statement
Key Adverse Reactions Predominantly Localized Cutaneous Reactions (irritation, dryness, peeling) and rare Systemic Hypersensitivity Reactions (anaphylaxis, angioedema).
Most Common Reactions Reactions classified as Very Common (ge 1/10 of patients) include dry skin, erythema (redness), skin exfoliation (peeling), and skin burning sensation.
Timing Pattern Local skin reactions are most likely to occur during the first few days to four weeks of treatment and typically lessen with continued use of the medication.
Serious Reactions Severe hypersensitivity reactions, including anaphylaxis and angioedema, have been reported post-marketing and are explicitly documented in regulatory warnings due to their severity.

Safety Constraints and Considerations

The official labeling includes specific restrictions for safe use:

  • Contraindication: The product is contraindicated in patients with a known history of hypersensitivity or allergy to Benzoyl Peroxide or any component of the formulation.
  • Photosensitivity Risk: The medication may increase sensitivity to sunlight. Regulatory documents advise minimizing or avoiding exposure to natural or artificial sunlight and using sun protection.
  • Application Restrictions: Application should be avoided on damaged skin, including cuts, abrasions, eczematous, or sunburned areas. The product should also not contact the eyes, mouth, nose angles, lips, or mucous membranes.
  • Population Note: Safety and effectiveness have not been established in children below 12 years of age based on current regulatory documents.

Connection to the Overall Safety Profile

The official safety information structures the risks as predictable, common, local irritations tied to the drug’s contact-dependent action, which often diminish over time. This profile is balanced by the rare but severe risk of systemic allergic reactions and mandatory constraints regarding application sites, sun exposure, and patient history, formalizing the necessary safety limitations for the drug's use.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of topical Benzoyl Peroxide (Acnecare) is defined by two primary scenarios: severe local toxicity and systemic emergency from hypersensitivity.


Documented Overdose Manifestations

Exposure Scenario Officially Documented Symptoms and Signs
Excessive Topical Use Severe local irritation characterized by marked erythema (redness), scaling, dryness, and intensified stinging/burning sensation. The development of contact dermatitis is also documented.
Severe Systemic Outcome Rare but serious Hypersensitivity Reactions including Anaphylaxis, Angioedema, throat tightness, difficulty breathing, swelling of the face/lips/tongue, and feeling faint or dizzy.

Required Emergency Actions

The regulatory guidance mandates specific actions based on the presentation:

  • Seek immediate medical attention and discontinue use if any signs of a serious hypersensitivity reaction occur, as these are classified as life-threatening systemic events.
  • If the product is accidentally swallowed, the instruction is to get medical help or contact a Poison Control Center right away.

No specific antidote is documented in the regulatory prescribing information. Management for toxicity is generally supportive and symptomatic. No special overdose considerations based on age or organ impairment are explicitly noted in the official labeling.

Therapeutic Uses of Acnecare

What Acnecare Treats: Main Uses and Benefits

Acnecare is commonly used to help address the symptoms of Acne Vulgaris, and is relevant for easing both visible red and swollen breakouts (papules and pustules) and non-inflamed blockages like blackheads and whiteheads (comedones). It is generally applied to help treat mild to moderate acne. This application may assist with easing the overall symptom load by supporting the reduction of visible blemishes and contributes to improved comfort during symptomatic periods.

The medication is commonly used during phases when symptoms become more noticeable due to active breakouts to help ease symptoms related to inflammatory or irritative states. It is applied across domains where additional symptomatic support is needed in long-term management of conditions characterized by recurrent or episodic manifestations. When applied in long-term management, the medication may assist with addressing symptoms associated with acute or episodic changes, supporting the process of minimizing the appearance of new lesions and contributing to easing the overall symptom load by managing future episode frequency.


Quick Fact: Relief for Inflammatory Symptoms
Supports the easing of symptoms related to inflammatory states, such as redness and swelling, contributing to improved comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Acnecare

Populations for whom use is allowed (as stated in label):

  • Adults and adolescents 12 years of age and older are generally approved for use.

Populations for whom use is contraindicated:

  • Patients with a documented history of hypersensitivity or allergy to benzoyl peroxide or any ingredient in the specific formulation must not use the medicine.

Age-related eligibility rules:

  • Use in children younger than 12 years of age is restricted; use must be determined by a healthcare provider.
  • For the older adult (geriatric) population, safety and effectiveness data have not been fully established for all products.

Eligibility-related restrictions:

  • Application must be avoided on broken, cut, scraped, sunburned, or eczematous skin.
  • Use is restricted on very sensitive skin.

Pregnancy and lactation eligibility status:

  • Pregnancy: Use is generally considered safe but is often advised only if clearly needed due to conditional regulatory guidance.
  • Lactation: Use is considered low-risk. Breastfeeding individuals must avoid applying the product to the chest area to prevent accidental infant exposure.

Connection to the overall eligibility profile: Regulatory documents define eligibility by establishing an absolute prohibition for individuals with component allergy. Use is then structured by age, permitting general use for those 12 and above. Further conditional limitations prohibit application to compromised skin or restrict use in women who are pregnant or breastfeeding, requiring specific precautions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for topical Benzoyl Peroxide (Acnecare) is defined primarily by local pharmacodynamic and chemical effects rather than systemic pharmacokinetic changes, which is consistent with its minimal absorption into the bloodstream. Regulatory documents do not list any formal contraindicated combinations based on systemic risk, nor do they cite interactions involving CYP enzymes or other drug transporters.


Documented Topical Interactions

The following interaction patterns are documented in official regulatory materials, establishing the necessary cautions for co-administration:

Interacting Substance/Class Official Interaction Description/Outcome
Other Topical Acne Agents Co-administration with peeling, desquamating, or abrasive agents may result in a cumulative irritancy effect on the skin, including increased scaling and dryness.
Topical Dapsone Concurrent use may cause a temporary local yellow or orange skin discoloration at the site of application.
Topical Tretinoin Benzoyl Peroxide can cause oxidation and degradation of the tretinoin molecule, leading to a reduction in efficacy of the tretinoin product.
Alcohol-Containing Products Avoid using products with high concentrations of alcohol, astringents, spices, or limes due to the risk of cumulative irritancy and excessive drying.

Systemic and Ingested Products

No formal interactions are documented by government regulators between topical Benzoyl Peroxide and ingested food, alcohol, or systemic medications. No mandatory timing rules for dose separation are explicitly established in monotherapy labels.

Mechanism of Action

Acnecare primarily engages the sebaceous gland to modulate sebum production. Its initial molecular function involves the competitive inhibition of the 5alpha-reductase enzyme. This enzyme catalyzes the conversion of testosterone into the androgen dihydrotestosterone (DHT). By inhibiting this conversion, Acnecare reduces the local availability of DHT, subsequently modulating the cellular activity and proliferation rate of sebocytes. This action influences follicular environment characteristics by altering lipid synthesis and secretion profiles. Furthermore, the compound modulates inflammatory signaling through interaction with the Toll-like Receptor 2 (TLR2) pathway. Upregulation of TLR2 is associated with increased innate immune response activation within the pilosebaceous unit. By modulating this pathway, Acnecare affects downstream intracellular cascades, leading to a reduction in the transcription and translation of various pro-inflammatory cytokines, which influences the integrity of the epidermal lipid structure.

Dosage and Administration Information

How to Use Acnecare: Official Administration Guidelines

The usage of Acnecare (Benzoyl Peroxide) is defined by established administration patterns, which specify the route, frequency, and preparatory steps for topical application. The product is exclusively intended for topical (cutaneous) use.


Administration Scope

Element Official Instruction
Route of Administration Topical (Cutaneous) administration only.
Dosing Schedule Initial application begins at once daily (a thin layer). The frequency may be gradually increased to twice or three times daily as tolerated, based on the specific product form.
Preparation The skin must be cleaned and dried before the product is applied. Wash or cleanser forms require gentle massage into a lather, followed by thorough rinsing with water and patting dry.
Age-Group Rules Standard regimens apply to individuals 12 years of age and over. For children under 12, use and dose must be determined by a healthcare provider.

Procedural Constraints

The official protocol includes specific handling rules to ensure proper use. Application must cover the entire affected area. If dryness or peeling occurs, the instructions direct users to reduce the application frequency to once a day or once every other day, or to temporarily stop use. Furthermore, contact with the eyes, mouth, nose, and other mucous membranes must be strictly avoided. The treatment course is continuous, with early signs of response typically observed within 1 to 4 weeks.

Recent Clinical Evidence

Research evidence / Overview of Studies for Acnecare

The evidence base for the active ingredient in Acnecare, Benzoyl Peroxide (BPO), comes primarily from Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. This research is generally categorized as having a High level of research strength based on multiple supporting trials.


Evidence for Use in Mild to Moderate Acne Vulgaris

The research primarily examined changes related to Acne Vulgaris, a condition characterized by fluctuating manifestations. These short-term RCTs (typically 6 to 12 weeks) mainly involved adolescents and young adults with mild to moderate acne severity. Researchers monitored specific outcomes related to physical discomfort, such as counting changes in acne spots. Studies that compared BPO versus a non-medicated vehicle consistently reported measurements of change in lesion counts that differed between the active treatment group and the control group.

The Study Landscape: Comparing Against Non-Medicated Controls

The research examined settings designed to compare measurements from the active BPO ingredient group versus the non-medicated base. Systematic reviews from authoritative sources described patterns of consistency across numerous trials when comparing the product to a non-medicated control, which contributes to the evidence base being assigned a High level.

Long-Term Data and Extended Follow-up

The pivotal clinical trials often had a limited follow-up duration of 6 to 12 weeks. The extent of long-term outcomes are not fully established by the highest-quality RCTs that extend beyond the 6-to-12-month period. Consequently, there is limited information for long-term outcomes regarding the sustained prevention of new lesion formation.

Evidence in Different Populations

The primary research that formed the basis for regulatory conclusions results apply only to the populations studied (adolescents and young adults). The available evidence is limited regarding dedicated research for certain groups; data for certain groups remain insufficient, such as for older adults or individuals presenting with complex concurrent health conditions.

What Research Gaps and Uncertainties Remain

A key limitation is that follow-up durations were limited in many core short-term RCTs, meaning existing studies provide limited insight into long-term patterns of use. Furthermore, the highest-quality evidence available research does not determine whether an individual will respond similarly to the measured group patterns. Comparative evidence against certain newer or more complex combination treatments is not yet available.

Key Studies & References

  1. Benzoyl Peroxide Topical Drug Information (MedlinePlus)
  2. Tretinoin Topical Drug Information (MedlinePlus) - Referenced for general acne severity context

Frequently Asked Questions (FAQ)

Common questions about Acnecare (FAQ)

Q: Is Acnecare meant for short-term treatment or long-term management?

The official usage guidelines describe the product's course of use as continuous. However, the available clinical studies establishing efficacy for regulatory review typically have a limited follow-up period of 6 to 12 weeks. Evidence regarding sustained effectiveness in long-term use is limited.

Q: Does Acnecare interact with common over-the-counter pain relievers?

Regulatory documents indicate that no formal interactions are documented between topical Acnecare (Benzoyl Peroxide) and common ingested pain relievers. This is due to the drug's minimal absorption into the bloodstream.

Q: What other types of prescription medicines are known to interact with Acnecare?

Official product information states that there are no formal interactions documented with systemic prescription medicines, consistent with its minimal absorption into the body. Documented interaction concerns are primarily limited to specific other topical acne products that may cause cumulative skin irritation.

Q: Does the use of hormonal birth control affect the effectiveness of Acnecare?

According to the official product information and safety documentation, there is no specific evidence documented to suggest that using topical Acnecare affects the effectiveness of hormonal birth control.

Q: What is the meaning of the warning about 'teratogenicity' regarding this drug?

While the term 'teratogenicity' (which refers to the potential to cause fetal harm) is not commonly used in the product label, regulatory agencies address this risk. Use during pregnancy is advised only if clearly needed. This guidance is consistent with the understanding that fetal risk is unlikely due to the drug’s minimal systemic absorption.

Q: Is Acnecare the generic name or a brand name?

Acnecare is the product's trade name or brand name. The active pharmaceutical ingredient is Benzoyl Peroxide, which is the generic name for the compound.

Q: Is it true that acne can worsen before it improves while using this medicine?

Official safety information indicates that local skin reactions like redness, peeling, and dryness are most common during the first few weeks of application. The official documentation focuses on localized reactions which are most common during the initial weeks, and these effects usually lessen with continued use.

Q: What are the general expectations about the duration of treatment with Acnecare?

Studies indicate that most individuals observe initial signs of response within 1 to 4 weeks of starting treatment. The overall treatment course is often continuous for control, but the long-term data available from the highest-quality studies is typically limited to follow-up periods of several months.

Q: Is Acnecare available in different strengths or forms?

Yes, the active ingredient Benzoyl Peroxide is available in topical preparations across a strength range of 2.5% to 10%. These are offered in diverse forms, including creams, gels, lotions, and washes, all designed for application to the skin.

Q: What happens if someone misses a dose of Acnecare?

Official product information describes the guidance for a missed application: the product is applied as soon as it is remembered, unless it is almost time for the next scheduled application. In that scenario, the direction is to skip the missed dose and continue the regular schedule.

Q: Is it possible to use Acnecare if I have other diagnosed skin conditions?

The official application rules describe a restriction on use on skin that is already damaged, such as areas with cuts, abrasions, or eczema. Regulatory evidence also indicates that the safety and effectiveness have not been fully established for individuals with other complex, concurrent skin conditions.

Q: What is Acnecare's official safety classification (e.g., in pregnancy categories)?

The active ingredient, Benzoyl Peroxide, is designated 'Not Assigned' under the new FDA pregnancy risk summary system. This is because the former letter-based categories (like A, B, C, D, X) are being phased out by the regulatory authority.

Q: Are there any known issues with combining Acnecare with herbal supplements?

Regulatory guidance does not specify formal interactions between topical Benzoyl Peroxide and herbal supplements. Regulatory guidance does, however, often include common counseling to inform a healthcare provider about all herbal and nutritional products being used.

Q: Does Acnecare treat only inflammatory acne or also non-inflammatory types?

Yes, the product is described in official documents as treating both types of acne lesions. It works on inflammatory lesions by its antiseptic action (reducing bacteria) and on non-inflammatory lesions by its keratolytic action (which helps clear follicular plugs).

Q: Is Acnecare considered a retinoid-type medication?

No, Acnecare (Benzoyl Peroxide) is officially classified as a topical anti-acne agent with antiseptic and keratolytic properties. It belongs to a different pharmacological class and is not considered a retinoid-type medication.

Q: What happens if I use more of the product than is recommended in the official instructions?

Regulatory information indicates that applying excess medicine will not make the product work faster. Doing so may only increase the risk of experiencing adverse reactions, such as severe skin irritation and excessive dryness.

How should Acnecare be stored and disposed of?

How to Store and Dispose of Acnecare

Official regulatory information requires Acnecare to be stored at controlled room temperature (typically below 25 C or 30 C). The product must be protected from freezing and should be kept away from excessive heat and moisture to maintain stability. Always keep the medication in its original container and ensure the container is tightly closed and out of the sight and reach of children.

After opening, some formulations must be discarded within a specific period (e.g., 60 days). For disposal, the preferred method is using an authorized drug take-back program. If one is unavailable, do not flush the medicine; instead, mix it with an undesirable substance, seal it in a bag, and place it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acnecare found in:

A-Z Index: